In the BioHarmony Drug Report Database

"Preview" Icon

Orlistat

Alli, Xenical, Orlistat GSK (orlistat) is a small molecule pharmaceutical. Orlistat was first approved as Alli on 1998-07-29. It is used to treat obesity in the USA. It has been approved in Europe to treat obesity. The pharmaceutical is active against pancreatic triacylglycerol lipase. In addition, it is known to target diacylglycerol lipase-alpha, diacylglycerol lipase-beta, and lysophosphatidylserine lipase ABHD12.

 

Trade Name

 

Alli, Orlistat GSK, Xenical
 

Common Name

 

orlistat
 

ChEMBL ID

 

CHEMBL175247
 

Indication

 

obesity
 

Drug Class

 

Enzyme inhibitors: gastrointestinal lipase inhibitors

Image (chem structure or protein)

Orlistat structure rendering